2 weeks Ago By ABMN Staff
Bokf Na lifted its stake in SPDR S&P Biotech ETF ( NYSEARCA:XBI – Free Report ) by 65.5% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 1,390 shares of the exchange traded fund’s stock after purchasing an additional 550 shares during the quarter.
Bokf Na’s holdings in SPDR S&P Biotech ETF were worth $129,000 at the end of the most recent reporting period. Several other institutional investors have also made changes to their positions in the stock. ICA Group Wealth Management LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $27,000.
Scarborough Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $32,000. BOCHK Asset Management Ltd bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $36,000. ORG Partners LLC bought a new stake in SPDR S&P Biotech ETF during the second quarter worth $40,000.
Finally, Vima LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth $45,000. SPDR S&P Biotech ETF Price Performance NYSEARCA XBI opened at $100.93 on Wednesday.
The business has a fifty day moving average price of $98.65 and a two-hundred day moving average price of $93.87.
SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52.
The stock has a market capitalization of $7.69 billion, a PE ratio of 11.47 and a beta of 1.
11. SPDR S&P Biotech ETF Company Profile SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index.
The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. Featured Articles Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF ( NYSEARCA:XBI – Free Report ).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter ..
